Estimaciones de analistas de Wall Street para ALX Oncology Holdings Inc. (ALXO): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 6 |
| Mantener | 1 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 7 |
| Calificación media (1-5) | 0.86 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-06 | $-0.15 | ||
| 2026-08-06 | $-0.13 | $-0.14 | +9.0% |
| 2026-05-08 | $-0.17 | $-0.15 | -13.3% |
| 2026-02-27 | $-0.42 | $-0.38 | -10.5% |
| 2025-11-07 | $-0.41 | $-0.37 | -10.8% |
| 2025-08-12 | $-0.49 | $-0.46 | -6.5% |
| 2025-05-08 | $-0.58 | $-0.47 | -23.4% |
| 2025-03-06 | $-0.55 | $-0.72 | +23.6% |
Ratios de valoración
| Precio / Valor contable | 1.75 |
| EV / EBITDA | -0.50 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | $2.1M | $4.8M | $1.2M | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $1.9M | $4.4M | $1.1M | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | $187000 | $436000 | $107000 | 0 | 0 | 0 | 0 | 0 |
| I+D | $11.3M | $16.3M | $29.0M | $60.2M | $98.4M | $141.8M | $116.4M | $77.0M |
| Generales y Administrativos | $2.6M | $3.3M | $14.8M | $23.4M | $29.0M | $28.5M | $26.1M | $23.9M |
| Gastos Operativos | $13.9M | $19.6M | $43.8M | $83.6M | $127.4M | $170.3M | $142.5M | $104.0M |
| Beneficio Operativo | -$13.7M | -$19.2M | -$43.7M | -$83.6M | -$127.4M | -$170.3M | -$142.5M | -$104.0M |
| EBITDA | -$13.3M | -$18.8M | -$43.5M | -$83.4M | -$122.8M | -$158.4M | -$132.2M | -$99.4M |
| Gastos por Intereses | 0 | $21000 | $811000 | $13000 | $238000 | $1.6M | $1.7M | $1.6M |
| Beneficio Antes de Impuestos | -$13.7M | -$19.2M | -$45.5M | -$83.5M | -$123.4M | -$160.8M | -$134.8M | -$101.7M |
| Impuestos | $45000 | $34000 | $241000 | -$21000 | $64000 | 0 | 0 | 0 |
| Beneficio Neto | -$13.7M | -$19.2M | -$45.7M | -$83.5M | -$123.5M | -$160.8M | -$134.8M | -$101.7M |
| BPA | $-0.79 | $-0.88 | $-1.28 | $-2.07 | $-3.03 | $-3.74 | $-2.58 | $-1.90 |
| BPA Diluido | $-0.79 | $-0.88 | $-1.28 | $-2.07 | $-3.03 | $-3.74 | $-2.58 | $-1.90 |
| Acciones en Circulación (Diluidas) | $22.0M | $22.0M | $39.8M | $40.3M | $40.7M | $43.0M | $52.2M | $53.7M |
Precio
| Precio | $1.76 |
| Capitalización | $237M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ANNX · BCYC · GLUE · KYMR · NKTX · STOK · TNYA
Explorar sector: Healthcare · Biotechnology
Más secciones de ALXO: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones